BACKGROUND: The relationship between depression and cerebrovascular disease (CBVD) continues to be debated although little research has compared the predictive power of depression for coronary heart disease (CHD) with that for CBVD within the same population. This study aimed to compare the importance of depression for CHD and CBVD within the same population of adults free of apparent cardiovascular disease. METHODS: A random sample of 23,282 adults (9507 men, 13,775 women) aged 20-54 years were followed up for 7 years. Fatal and first non-fatal CHD and CBVD events were documented by linkage to the National-hospital-discharge and mortality registers. RESULTS: Sex-age-education-adjusted hazard ratio (HR) for CHD was 1.66 [95% confidence interval (CI) 1.24-2.24] for participants with mild to severe depressive symptoms, i.e. those scoring > or =10 on the 21-item Beck Depression Inventory, and 2.04 (1.27-3.27) for those who filled antidepressant prescriptions compared with those without depression markers in 1998, i.e. at study baseline. For CBVD, the corresponding HRs were 1.01 (0.67-1.53) and 1.77 (0.95-3.29). After adjustment for behavioural and biological risk factors these associations were reduced but remained evident for CHD, the adjusted HRs being 1.47 (1.08-1.99) and 1.72 (1.06-2.77). For CBVD, the corresponding multivariable adjusted HRs were 0.87 (0.57-1.32) and 1.52 (0.81-2.84). CONCLUSIONS: Self-reported depression using a standardized questionnaire and clinical markers of mild to severe depression were associated with an increased risk for CHD. There was no clear evidence that depression is a risk factor for CBVD, but this needs further confirmation.
BACKGROUND: The relationship between depression and cerebrovascular disease (CBVD) continues to be debated although little research has compared the predictive power of depression for coronary heart disease (CHD) with that for CBVD within the same population. This study aimed to compare the importance of depression for CHD and CBVD within the same population of adults free of apparent cardiovascular disease. METHODS: A random sample of 23,282 adults (9507 men, 13,775 women) aged 20-54 years were followed up for 7 years. Fatal and first non-fatal CHD and CBVD events were documented by linkage to the National-hospital-discharge and mortality registers. RESULTS: Sex-age-education-adjusted hazard ratio (HR) for CHD was 1.66 [95% confidence interval (CI) 1.24-2.24] for participants with mild to severe depressive symptoms, i.e. those scoring > or =10 on the 21-item Beck Depression Inventory, and 2.04 (1.27-3.27) for those who filled antidepressant prescriptions compared with those without depression markers in 1998, i.e. at study baseline. For CBVD, the corresponding HRs were 1.01 (0.67-1.53) and 1.77 (0.95-3.29). After adjustment for behavioural and biological risk factors these associations were reduced but remained evident for CHD, the adjusted HRs being 1.47 (1.08-1.99) and 1.72 (1.06-2.77). For CBVD, the corresponding multivariable adjusted HRs were 0.87 (0.57-1.32) and 1.52 (0.81-2.84). CONCLUSIONS: Self-reported depression using a standardized questionnaire and clinical markers of mild to severe depression were associated with an increased risk for CHD. There was no clear evidence that depression is a risk factor for CBVD, but this needs further confirmation.
Authors: Ralph L Sacco; Robert Adams; Greg Albers; Mark J Alberts; Oscar Benavente; Karen Furie; Larry B Goldstein; Philip Gorelick; Jonathan Halperin; Robert Harbaugh; S Claiborne Johnston; Irene Katzan; Margaret Kelly-Hayes; Edgar J Kenton; Michael Marks; Lee H Schwamm; Thomas Tomsick Journal: Stroke Date: 2006-02 Impact factor: 7.914
Authors: Kimberly J Salaycik; Margaret Kelly-Hayes; Alexa Beiser; Anh-Hoa Nguyen; Stephen M Brady; Carlos S Kase; Philip A Wolf Journal: Stroke Date: 2006-11-30 Impact factor: 7.914
Authors: Lonneke Wouts; Richard C Oude Voshaar; Marijke A Bremmer; Jan K Buitelaar; Brenda W J H Penninx; Aartjan T F Beekman Journal: Arch Gen Psychiatry Date: 2008-05
Authors: M J Bos; T Lindén; P J Koudstaal; A Hofman; I Skoog; M M B Breteler; H Tiemeier Journal: J Neurol Neurosurg Psychiatry Date: 2008-01-21 Impact factor: 10.154
Authors: Judith H Lichtman; J Thomas Bigger; James A Blumenthal; Nancy Frasure-Smith; Peter G Kaufmann; François Lespérance; Daniel B Mark; David S Sheps; C Barr Taylor; Erika Sivarajan Froelicher Journal: Circulation Date: 2008-09-29 Impact factor: 29.690
Authors: Mika Kivimaki; Adam G Tabak; G David Batty; Archana Singh-Manoux; Markus Jokela; Tasnime N Akbaraly; Daniel R Witte; Eric J Brunner; Michael G Marmot; Debbie A Lawlor Journal: Diabetes Care Date: 2009-07-10 Impact factor: 19.112
Authors: An Pan; Olivia I Okereke; Qi Sun; Giancarlo Logroscino; JoAnn E Manson; Walter C Willett; Alberto Ascherio; Frank B Hu; Kathryn M Rexrode Journal: Stroke Date: 2011-08-11 Impact factor: 7.914
Authors: Iffat Rahman; Keith Humphreys; Anna Michaela Bennet; Erik Ingelsson; Nancy Lee Pedersen; Patrik Karl Erik Magnusson Journal: Eur J Epidemiol Date: 2013-07-09 Impact factor: 8.082
Authors: Wendy M Troxel; David J Kupfer; Charles F Reynolds; Ellen Frank; Michael E Thase; Jean M Miewald; Daniel J Buysse Journal: J Clin Psychiatry Date: 2011-11-29 Impact factor: 4.384
Authors: Thomas Lefèvre; Archana Singh-Manoux; Silvia Stringhini; Aline Dugravot; Cédric Lemogne; Silla M Consoli; Marcel Goldberg; Marie Zins; Hermann Nabi Journal: Eur J Public Health Date: 2011-08-11 Impact factor: 3.367
Authors: Hermann Nabi; Jean-François Chastang; Thomas Lefèvre; Aline Dugravot; Maria Melchior; Michael G Marmot; Martin J Shipley; Mika Kivimäki; Archana Singh-Manoux Journal: Hypertension Date: 2011-02-21 Impact factor: 10.190